{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:55:43Z","timestamp":1779173743578,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10461-021-03286-w","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T20:48:26Z","timestamp":1620074906000},"page":"4169-4179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7189-8669","authenticated-orcid":false,"given":"Marie C. D.","family":"Stoner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila E.","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tchangani","family":"Tembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonasagrie","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyne","family":"Akello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linly","family":"Seyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesha","family":"Jeenarain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logashvari","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyaradzo","family":"Mgodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Portia","family":"Hunidzarira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miria","family":"Chitukuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the MTN-020 ASPIRE and M-025 HOPE study teams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyaradzo","family":"Mgodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Soto-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonus","family":"Makanani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lameck","family":"Chinula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonasagrie","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaneshree","family":"Govender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Siva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakir","family":"Gaffoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logashvari","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arendevi","family":"Pather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesha","family":"Jeenarain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gita","family":"Ramjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dishiki","family":"Kalonji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishanta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Matovu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Gati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Portia","family":"Hunidzarira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Mhlanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"issue":"5","key":"3286_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"key":"3286_CR2","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375:2121\u201332.","journal-title":"N Engl J Med"},{"issue":"22","key":"3286_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel A, Van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375(22):2133\u201343.","journal-title":"N Engl J Med"},{"key":"3286_CR4","doi-asserted-by":"crossref","first-page":"e25634","DOI":"10.1002\/jia2.25634","volume":"23","author":"E Browne","year":"2020","unstructured":"Browne E, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee-Phillips T, et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition. JIAS. 2020;23:e25634.","journal-title":"JIAS"},{"key":"3286_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182986f69","author":"JM Baeten","year":"2013","unstructured":"Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? J Acquir Immune Defic Syndr. 2013. https:\/\/doi.org\/10.1097\/QAI.0b013e3182986f69.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3286_CR6","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African Women. N Engl J Med. 2015;372:509\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1402269 ([Internet]).","journal-title":"N Engl J Med"},{"key":"3286_CR7","doi-asserted-by":"crossref","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411\u201322. Available from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22784040","DOI":"10.1056\/NEJMoa1202614"},{"key":"3286_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02799-0","author":"AWK Katz","year":"2020","unstructured":"Katz AWK, Naidoo K, Reddy K, Chitukuta M, Nabukeera J, Siva S, et al. The power of the shared experience: MTN-020\/ASPIRE trial participants\u2019 descriptions of peer influence on acceptability of and adherence to the dapivirine vaginal ring for HIV prevention. AIDS Behav. 2020. https:\/\/doi.org\/10.1007\/s10461-020-02799-0.","journal-title":"AIDS Behav"},{"issue":"5","key":"3286_CR9","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10461-019-02715-1","volume":"24","author":"EN Browne","year":"2020","unstructured":"Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, et al. Efficacy is not everything: eliciting women\u2019s preferences for a vaginal HIV prevention product using a discrete-choice experiment. AIDS Behav. 2020;24(5):1443\u201351. https:\/\/doi.org\/10.1007\/s10461-019-02715-1.","journal-title":"AIDS Behav"},{"issue":"4","key":"3286_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/QAI.0000000000001945","volume":"80","author":"AM Minnis","year":"2019","unstructured":"Minnis AM, Browne EN, Boeri M, Agot K, Van Der Straten A, Ahmed K, et al. Young women\u2019s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019;80(4):394\u2013403. https:\/\/doi.org\/10.1097\/QAI.0000000000001945.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"3286_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/apc.2012.0419","volume":"27","author":"SA Golub","year":"2013","unstructured":"Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248\u201354. https:\/\/doi.org\/10.1089\/apc.2012.0419.","journal-title":"AIDS Patient Care STDS"},{"issue":"11","key":"3286_CR12","doi-asserted-by":"publisher","first-page":"e005717","DOI":"10.1136\/bmjopen-2014-005717","volume":"4","author":"I Young","year":"2014","unstructured":"Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11):e005717. https:\/\/doi.org\/10.1136\/bmjopen-2014-005717.","journal-title":"BMJ Open"},{"issue":"5","key":"3286_CR13","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10461-016-1627-z","volume":"21","author":"FM Koechlin","year":"2017","unstructured":"Koechlin FM, Fonner VA, Dalglish SL, O\u2019Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325\u201335. https:\/\/doi.org\/10.1007\/s10461-016-1627-z.","journal-title":"AIDS Behav"},{"issue":"5","key":"3286_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/QAI.0000000000001866","volume":"79","author":"T Palanee-Phillips","year":"2018","unstructured":"Palanee-Phillips T, Roberts ST, Reddy K, Govender V, Naidoo L, Siva S, et al. Impact of partner-related social harms on women\u2019s adherence to the dapivirine vaginal ring during a phase III trial. J Acquir Immune Defic Syndr. 2018;79(5):580\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000001866.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"3286_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s10461-019-02707-1","volume":"24","author":"ST Roberts","year":"2020","unstructured":"Roberts ST, Nair G, Baeten JM, Palanee-Philips T, Schwartz K, Reddy K, et al. Impact of male partner involvement on women\u2019s adherence to the dapivirine vaginal ring during a phase III HIV prevention trial. AIDS Behav. 2020;24(5):1432\u201342. https:\/\/doi.org\/10.1007\/s10461-019-02707-1.","journal-title":"AIDS Behav"},{"issue":"8","key":"3286_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, Van Der Straten A, Chitukuta M, Reddy K, Woeber K, Atujuna M, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159\u201367. https:\/\/doi.org\/10.1097\/QAD.0000000000001452.","journal-title":"AIDS"},{"issue":"6","key":"3286_CR17","doi-asserted-by":"publisher","first-page":"e25536","DOI":"10.1002\/jia2.25536","volume":"23","author":"A van der Straten","year":"2020","unstructured":"van der Straten A, Ryan JH, Reddy K, Etima J, Taulo F, Mutero P, et al. Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study. J Int AIDS Soc. 2020;23(6):e25536. https:\/\/doi.org\/10.1002\/jia2.25536.","journal-title":"J Int AIDS Soc"},{"key":"3286_CR18","first-page":"373","volume":"34","author":"LD Wagner","year":"2018","unstructured":"Wagner LD, Roberts ST, O\u2019Rourke S, Celum C, Baeten JM, Bukusi E, et al. Challenges with oral pre-exposure prophylaxis (PrEP) disclosure among adolescent girls and young women (AGYW) in Kenya and South Africa. JAIDS Res Hum Retroviruses. 2018;34:373.","journal-title":"JAIDS Res Hum Retroviruses"},{"issue":"7","key":"3286_CR19","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10461-018-2376-y","volume":"23","author":"SA Golub","year":"2019","unstructured":"Golub SA, Fikslin RA, Goldberg MH, Pe\u00f1a SM, Radix A. Predictors of PrEP uptake among patients with equivalent access. AIDS Behav. 2019;23(7):1917\u201324. https:\/\/doi.org\/10.1007\/s10461-018-2376-y.","journal-title":"AIDS Behav"},{"issue":"4","key":"3286_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10461-017-1675-z","volume":"22","author":"P Peng","year":"2018","unstructured":"Peng P, Su S, Fairley CK, Chu M, Jiang S, Zhuang X, et al. A global estimate of the acceptability of pre-exposure prophylaxis for HIV among men who have sex with men: a systematic review and meta-analysis. AIDS Behav. 2018;22(4):1063\u201374. https:\/\/doi.org\/10.1007\/s10461-017-1675-z.","journal-title":"AIDS Behav"},{"issue":"1","key":"3286_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/QAI.0000000000001762","volume":"79","author":"SK Calabrese","year":"2018","unstructured":"Calabrese SK, Dovidio JF, Tekeste M, Taggart T, Galvao RW, Safon CB, et al. HIV pre-exposure prophylaxis stigma as a multidimensional barrier to uptake among women who attend planned parenthood. J Acquir Immune Defic Syndr. 2018;79(1):46\u201353. https:\/\/doi.org\/10.1097\/QAI.0000000000001762.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"3286_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/09540121.2012.748871","volume":"25","author":"A Tangmunkongvorakul","year":"2013","unstructured":"Tangmunkongvorakul A, Chariyalertsak S, Rivet Amico K, Saokhieo P, Wannalak V, Sangangamsakun T, et al. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care. 2013;25(8):961\u20137. https:\/\/doi.org\/10.1080\/09540121.2012.748871.","journal-title":"AIDS Care"},{"issue":"3","key":"3286_CR23","doi-asserted-by":"publisher","first-page":"e1001613","DOI":"10.1371\/journal.pmed.1001613","volume":"11","author":"A Liu","year":"2014","unstructured":"Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11(3):e1001613. https:\/\/doi.org\/10.1371\/journal.pmed.1001613.","journal-title":"PLoS Med"},{"key":"3286_CR24","unstructured":"Baeten J, Palanee-Phillips T, Mgodi N, Mayo A, Nel A, Rosenberg Z, et al. High uptake and reduced HIV-1 incidence in an open-label trial of the dapivirine ring. In: Confrence on Retroviruses and Opportunistic Infections (CROI); 2018 Mar 4\u20137; Boston, Massachusetts."},{"issue":"2","key":"3286_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10461-018-2261-8","volume":"23","author":"BS Mensch","year":"2019","unstructured":"Mensch BS, Richardson BA, Husnik M, Brown ER, Kiweewa FM, Mayo AJ, et al. Vaginal ring use in a phase 3 microbicide trial: a comparison of objective measures and self-reports of non-adherence in ASPIRE. AIDS Behav. 2019;23(2):504\u201312. https:\/\/doi.org\/10.1007\/s10461-018-2261-8.","journal-title":"AIDS Behav"},{"issue":"11","key":"3286_CR26","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s10461-016-1406-x","volume":"20","author":"IB Wilson","year":"2016","unstructured":"Wilson IB, Lee Y, Michaud J, Fowler FJ, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20(11):2700\u20138. https:\/\/doi.org\/10.1007\/s10461-016-1406-x.","journal-title":"AIDS Behav"},{"issue":"11","key":"3286_CR27","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1007\/s10461-016-1312-2","volume":"20","author":"BS Mensch","year":"2016","unstructured":"Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje ZM, Gomez K, et al. Reporting of adherence in the VOICE trial: did disclosure of product nonuse increase at the termination visit? AIDS Behav. 2016;20(11):2654\u201361. https:\/\/doi.org\/10.1007\/s10461-016-1312-2.","journal-title":"AIDS Behav"},{"key":"3286_CR28","unstructured":"International Partnership forMicrobicides. IPM\u2019s dapivirine ring for women\u2019s HIV prevention receives WHO prequalification. 2020 [cited 2020 Dec 8]. Available from https:\/\/www.ipmglobal.org\/content\/ipm\u2019s-dapivirine-ring-women\u2019s-hiv-prevention-receives-who-prequalification"},{"key":"3286_CR29","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.19.7.21120","author":"GP Cairns","year":"2016","unstructured":"Cairns GP, Race K, Goicochea P. PrEP: controversy, agency and ownership. J Int AIDS Soc. 2016. https:\/\/doi.org\/10.7448\/IAS.19.7.21120.","journal-title":"J Int AIDS Soc"},{"key":"3286_CR30","unstructured":"Koechlin FM, Fonner VA, Dalglish SL, O\u2019Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21:1325\u201335. Available from https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-85000785127&doi=10.1007%2Fs10461-016-1627-z&partnerID=40&md5=cc47a59dd09f09e723e4cc32da4467ca"},{"key":"3286_CR31","unstructured":"Gati Mirembe B, Cabrera MV, Cobbing M, Mgodi N, Palanee TP, Mayo A, Dadabhai S, Mansoor LE, Siva S, Nair G, Akello CA, Nakabiito C, Soto-Torres LE, van der Straten A, Baeten JM, et al. Correlates of dapivirine vaginal ring uptake and acceptance among women participating in an open label extension trial-MTN-025\/HOPE. In: 4th HIV Res Prev Conf (HIVR4P). Virtual; 2020. https:\/\/programme.hivr4p.org\/Abstract\/Abstract\/605."},{"key":"3286_CR32","doi-asserted-by":"publisher","first-page":"20642","DOI":"10.7448\/IAS.19.1.20642","volume":"19","author":"A Van Der Straten","year":"2016","unstructured":"Van Der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, et al. Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study. J Int AIDS Soc. 2016;19:20642.","journal-title":"J Int AIDS Soc"},{"key":"3286_CR33","volume-title":"The influence of HIV-related stigma on PrEP disclosure and adherence over time among AGYW in HPTN 082","author":"J Velloza","year":"2019","unstructured":"Velloza J. The influence of HIV-related stigma on PrEP disclosure and adherence over time among AGYW in HPTN 082. Miami, Florida: IAPAC Adherence Conf; 2019."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03286-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03286-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:15:00Z","timestamp":1698992100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03286-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3286"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03286-w","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"23 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The trial protocol was approved by the ethics review committee at each site.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}